Showing results (231-240 of 443) with videos related to
Sort By:
Pageof 45
Journal of Neuro-Oncology|March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanomaMorris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.Brain Pathology (Zurich, Switzerland)|June 6, 2020
cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumorsDavid W Ellison, Kenneth D Aldape, David Capper, et al.Acta Neuropathologica|September 11, 2024
HOXD12 defines an age-related aggressive subtype of oligodendrogliomaNicholas Nuechterlein, Sadie Cimino, Allison Shelbourn, et al.Journal of Neurosurgery|November 4, 2008
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trialEdward G Shaw, Brian Berkey, Stephen W Coons, et al.Molecular Oncology|December 2, 2021
Cysteine is a limiting factor for glioma proliferation and survivalVictor Ruiz-Rodado, Tyrone Dowdy, Adrian Lita, et al.Journal of Neuro-Oncology|April 28, 2006
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant statusMorris D Groves, Vinay K Puduvalli, Charles A Conrad, et al.CNS Oncology|February 10, 2022
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology BranchOrwa Aboud, Ritu Shah, Elizabeth Vera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802Edward G Shaw, Meihua Wang, Stephen W Coons, et al.BMC Cancer|March 2, 2018
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four casesSurabhi Ranjan, Martha Quezado, Nancy Garren, et al.Cancers|May 17, 2019
A Transgenic Mouse Model of Pacak⁻Zhuang Syndrome with An Epas1 Gain-of-Function MutationHerui Wang, Jing Cui, Chunzhang Yang, et al.Pageof 45